icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Aug 27-29
Digital ILC 2020
Back grey_arrow_rt.gif
 
 
 
Risk of end-stage renal disease among hepatitis C patients with chronic kidney disease treated with and without sofosbuvir
 
 
  EASL 2020 virtual Aug 27-29
Reported by Jules Levin
 
Laura E. Telep1,2, Meghan Sise3, Lindsey Force1, Anuj Gaggar1, Anand P. Chokkalingam1,2 1 Gilead Sciences, Foster City, CA USA; 2 School of Public Health, University of California, Berkeley, CA, USA; 3 Department of Medicine, Division of Nephrology, Massachusetts General Hospital, Boston, MA, USA

0904201

0904202

0904203

0904204

0904205